Clinical Memory Research
1151 – 1200 of 1268
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
A 76-year-old man with cognitive and neurological symptoms
(
- Contribution to journal › Article
- 2008
-
Mark
C4BP binds also to dead cells outside the blood compartment
(
- Contribution to journal › Published meeting abstract
-
Mark
{gamma}-Secretase and metalloproteinase activity regulate the distribution of endoplasmic reticulum to hippocampal neuron dendritic spines.
(
- Contribution to journal › Article
-
Mark
Long-term treatment response, predictors and biochemical markers in Alzheimer’s disease.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Effects of a goal-oriented rehabilitation program in mild cognitive impairment: A pilot study
(
- Contribution to journal › Article
-
Mark
Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.
(
- Contribution to journal › Article
-
Mark
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides
(
- Contribution to journal › Article
-
Mark
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cube Copying Test in Combination with rCBF or CSF Abeta(42)Predicts Development of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
rCBF pathology in Alzheimer's disease is associated with slow processing speed
(
- Contribution to journal › Article
-
Mark
The usefulness of cube copying for evaluating treatment of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein in Alzheimer's disease: Binding to Abeta(1-42) and to dead cells.
(
- Contribution to journal › Article
-
Mark
TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha 1-antitrypsin
(
- Contribution to journal › Article
-
Mark
Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting.
(
- Contribution to journal › Article
-
Mark
The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Association of complement factor HY402H gene polymorphism with Alzheimer's disease
(
- Contribution to journal › Article
- 2007
-
Mark
Patients with Lewy body dementia use more resources than those with Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
A quick test for cognitive speed: a measure of cognitive speed in dementia with lewy bodies.
(
- Contribution to journal › Article
-
Mark
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
(
- Contribution to journal › Article
-
Mark
Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients
(
- Contribution to journal › Article
-
Mark
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease and dementia with Lewy bodies: Special focus on the role of serpins
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Patients With Dementia With Lewy Bodies Have More Impaired Quality of Life Than Patients With Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease - Safety and dropout in long-term galantamine treatment in a routine clinical setting
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Activities of daily living - Outcome during two years in galantamine treated Alzheimer patients
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
(
- Contribution to journal › Article
-
Mark
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using the CSF Abeta42/Abeta40 Ratio in Patients with Mild Cognitive Impairment.
(
- Contribution to journal › Article
-
Mark
Longitudinal stability of CSF biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Activities of Daily Living – Outcome During Three Years in Donepezil Treated Alzheimer Patients.
2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress(
- Contribution to conference › Poster
-
Mark
Three-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress(
- Contribution to conference › Poster
- 2006
-
Mark
CSF Biomarkers for Alzheimer's Disease: Levels of beta-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival.
(
- Contribution to journal › Article
-
Mark
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
(
- Contribution to journal › Article
-
Mark
Corticosterone-Induced Inhibition of Gliogenesis in Rat Hippocampus is Counteracted by Electroconvulsive Seizures.
(
- Contribution to journal › Article
-
Mark
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
(
- Contribution to journal › Article
-
Mark
Demensvården behöver reformeras. Resurserna används inte optimalt - dags att evidensbasera vården
(
- Contribution to journal › Article
-
Mark
Om möss och människor. Inte givet att fynd hos alzheimermöss kan appliceras i klinisk verklighet
(
- Contribution to journal › Article
-
Mark
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
(
- Contribution to journal › Article
-
Mark
Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
2006) 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy(
- Contribution to conference › Poster
-
Mark
New regression models for long-term cognitive change in Donepezil treated Alzheimer patients.
2006) 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy(
- Contribution to conference › Poster
-
Mark
2-års resultat av rivastigmin (Exelon®) behandling vid Alzheimers sjukdom i klinisk vardag.
2006) Läkarstämman 2006(
- Contribution to conference › Poster
- 2005
-
Mark
Lower Gait Speed in Older Women with Dementia Compared with Controls.
(
- Contribution to journal › Article